CMS Finalizes Rules to Improve Healthcare Price and Coverage Transparency
The updated rules require health plans to publish clear, accessible pricing information
The updated rules require health plans to publish clear, accessible pricing information
Oral diseases cost Americans almost $140 billion annually. What will it take to bring these costs down? The post If We Treated Tooth Decay Like We Treat Heart Disease, We’d Save Billions appeared first on MedCity News.
By reimagining clinical trials as the initial step in designing a service ecosystem, organizations can accelerate time to delivery and lay the groundwork for successful commercialization. The post Building Service Infrastructure for “Made-To-Order” Therapies appeared first on MedCity News.
Community oncology practice believes responding to patient symptoms earlier will keep patients out of the ER or hospital
This brief provides an overview of deaths in ICE custody and detention centers under the Trump administration based on KFF analysis of ICE detainee death reporting and news releases and reviews recent reports of health care issues in detention centers.
[Sponsored] The webinar, scheduled for May 22, will include executives from PurpleLab and feature Genentech Principal Informatics Systems Lead Dr. Ben Freiberg. Register today! The post Eliminating Blind Spots in the Patient Journey appeared first on MedCity News.
The scaling power of AI can simultaneously remove barriers to access, drive costs down system-wide and elevate the role of the human clinician so they can focus on human touch that their patients need. The post Establishing Better Health Care Outcomes through AI appeared first on MedCity News.
New research shows that while health systems are pouring money into AI tools, most are still struggling to use the technology to meaningfully engage patients. Moving beyond generic outreach to “N-of-1 personalization” could be key to closing engagement gaps and improving patient outcomes at scale, said Amy Bucher, chief behavioral officer at Lirio. The post…
The new drug payment initiative is designed to negotiate fairer prices for Medicaid
Viking Therapeutics’ obesity pill met weight reduction goals of its Phase 2 test, but gastrointestinal side effects led to high discontinuation rates. Even so, analysts see potential for a lower dose of the Viking drug as a maintenance therapy. The post Side Effects Make Viking’s Oral Obesity Drug a Tough Pill for Investors to Swallow…